These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12107614)

  • 21. Retention rates in placebo- and nonplacebo-controlled clinical trials of schizophrenia.
    Labelle A; Boulay LJ; Lapierre YD
    Can J Psychiatry; 1999 Nov; 44(9):887-92. PubMed ID: 10584158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical trial of oxyprothepin decanoate (author's transl)].
    Kabes J; Balon R; Hanzlícek L; Skovajsová M; Kozáková H
    Cesk Psychiatr; 1980 Feb; 76(1):16-25. PubMed ID: 6103755
    [No Abstract]   [Full Text] [Related]  

  • 23. Isofloxythepine in an open study.
    Papezová H; David I; Alda M; Soucek R
    Act Nerv Super (Praha); 1989 Jun; 31(2):121-2. PubMed ID: 2572133
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical effectiveness of isofloxythepin--an open study].
    Zapletálek M; Tůma I; Kudrnová K
    Cesk Psychiatr; 1985 Aug; 81(4):242-6. PubMed ID: 2864141
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is it always necessary to use the double-blind method in controlled clinical trials?].
    Soto J
    Med Clin (Barc); 1996 Jun; 107(4):158-9. PubMed ID: 8754490
    [No Abstract]   [Full Text] [Related]  

  • 26. The cult of the double-blind placebo-controlled trial.
    Ellis SJ; Adams RF
    Br J Clin Pract; 1997; 51(1):36-9. PubMed ID: 9158270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxyprothepin and clorotepin compared in the hyperkinetic syndrome.
    Výborová L; Náhunek K; Drtilková I; Balastíková B
    Act Nerv Super (Praha); 1989 Apr; 31(1):45-6. PubMed ID: 2571227
    [No Abstract]   [Full Text] [Related]  

  • 28. Active-controlled versus placebo-controlled trials.
    Friedman JH
    Med Health R I; 1999 Jun; 82(6):186. PubMed ID: 10402831
    [No Abstract]   [Full Text] [Related]  

  • 29. Cis(Z)-clopenthixol. The neuroleptically active isomer of clopenthixol. A presentation of five double-blind clinical investigations and other studies with cis(Z)-clopenthixol (Cisordinol, Clopixol).
    Gravem A; Elgen K
    Acta Psychiatr Scand Suppl; 1981; 294():5-12. PubMed ID: 6122337
    [No Abstract]   [Full Text] [Related]  

  • 30. Cis(Z)-clopenthixol. The neuroleptically active isomer of clopenthixol. A presentation of five double-blind clinical investigations and other studies with cis(Z)-clopenthixol (Cisordinol, Clopixol).
    Acta Psychiatr Scand Suppl; 1981; 294():1-77. PubMed ID: 6122336
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical trials. Controlled or double blind?
    Bridges-Webb C
    Aust Fam Physician; 1984 Sep; 13(9):680. PubMed ID: 6508650
    [No Abstract]   [Full Text] [Related]  

  • 32. A critique of the double-blind clinical trial. Part 2.
    Kiene H
    Altern Ther Health Med; 1996 Mar; 2(2):59-64. PubMed ID: 8795890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Double-blind or open mind?].
    Huttunen JK
    Duodecim; 1986; 102(16):1129-33. PubMed ID: 3757849
    [No Abstract]   [Full Text] [Related]  

  • 34. Further clinical experience with oxyprothepin-decanoate.
    Kalvach Z; Hálková E; Bastecký J
    Act Nerv Super (Praha); 1981 Dec; 23(4):271-2. PubMed ID: 6121440
    [No Abstract]   [Full Text] [Related]  

  • 35. Medication guesses in double-blind studies.
    Rickels K
    Am J Psychiatry; 2010 Sep; 167(9):1128-9; author reply 1129. PubMed ID: 20826862
    [No Abstract]   [Full Text] [Related]  

  • 36. Special issue on active controlled clinical trials: guest editor's note.
    Tsong Y
    J Biopharm Stat; 2007; 17(2):197-9. PubMed ID: 17365217
    [No Abstract]   [Full Text] [Related]  

  • 37. Double-blind controlled studies.
    Singhal BS; Ladiwala U
    J Assoc Physicians India; 1994 Aug; 42(8):669-70. PubMed ID: 7868580
    [No Abstract]   [Full Text] [Related]  

  • 38. [The controlled study and the double-blind one].
    Riis P
    Ugeskr Laeger; 1971 Oct; 133(40):1980. PubMed ID: 4941897
    [No Abstract]   [Full Text] [Related]  

  • 39. Sample size and power calculations in repeated measurement analysis.
    Ahn C; Overall JE; Tonidandel S
    Comput Methods Programs Biomed; 2001 Feb; 64(2):121-124. PubMed ID: 11137194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitations of controlled double-blind studies of drugs.
    Cotzias GC
    N Engl J Med; 1972 Nov; 287(18):937. PubMed ID: 4561673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.